Sign Up to like & get
recommendations!
2
Published in 2022 at "British journal of haematology"
DOI: 10.1111/bjh.18185
Abstract: Immunomodulatory imide drugs (IMiDs), proteasome inhibitors (PIs) and anti-CD38 monoclonal antibodies (MoAbs) are the pillars of modern multiple myeloma (MM) therapy. The prognosis of patients with MM that became refractory to these three classes (triple-class…
read more here.
Keywords:
multiple myeloma;
triple class;
class refractory;
Sign Up to like & get
recommendations!
1
Published in 2022 at "Current Oncology"
DOI: 10.3390/curroncol29070355
Abstract: Major progress has been made in the upfront treatment of multiple myeloma, but the disease ultimately relapses and leads to death in the vast majority of those afflicted. New treatment strategies and modalities are necessary…
read more here.
Keywords:
refractory;
triple class;
myeloma;
treatment ... See more keywords